ライブラリ登録: Guest
Critical Reviews™ in Eukaryotic Gene Expression

年間 6 号発行

ISSN 印刷: 1045-4403

ISSN オンライン: 2162-6502

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.6 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.2 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00058 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.33 SJR: 0.345 SNIP: 0.46 CiteScore™:: 2.5 H-Index: 67

Indexed in

Is Cannabidiol a Promising Substance for New Drug Development? A Review of its Potential Therapeutic Applications

巻 28, 発行 1, 2018, pp. 73-86
DOI: 10.1615/CritRevEukaryotGeneExpr.2018021528
Get accessGet access

要約

The pharmacological importance of cannabidiol (CBD) has been in study for several years. CBD is the major nonpsychoactive constituent of plant Cannabis sativa and its administration is associated with reduced side effects. Currently, CBD is undergoing a lot of research which suggests that it has no addictive effects, good safety profile and has exhibited powerful therapeutic potential in several vital areas. It has wide spectrum of action because it acts through endocannabinoid receptors; CB1 and CB2 and it also acts on other receptors, such as GPR18, GPR55, GPR 119, 5HT1A, and TRPV2. This indicates its therapeutic value for numerous medical conditions because of its neuroprotective and immunomodulatory properties. Potential therapeutic applications of CBD include, analgesic, anti-inflammatory, anxiolytic, anti-arthritic, anti-depressant, anti-Alzheimer disease, anti-ischemic, neuroprotective, and anti-fibrotic. More promising areas appear to include diabetes and cancer where CBD exhibits lesser side effects and more therapeutic benefits as compared to recent available medical therapies. Hence, CBD is a promising substance for the development of new drug. However further research and clinical studies are required to explore its complete potential.

によって引用された
  1. Cogan Peter S., On healthcare by popular appeal: critical assessment of benefit and risk in cannabidiol based dietary supplements, Expert Review of Clinical Pharmacology, 12, 6, 2019. Crossref

  2. Vogt Nadine A., Sargeant Jan M., Stevens Christian P. G., Dunn Jennifer N., Clegg Simon Russell, A survey of veterinary student attitudes concerning whether marijuana could have therapeutic value for animals, PLOS ONE, 14, 7, 2019. Crossref

  3. Tassorelli Cristina, Greco Rosaria, Silberstein Stephen D., The endocannabinoid system in migraine: from bench to pharmacy and back, Current Opinion in Neurology, 32, 3, 2019. Crossref

  4. Tang Runhong, Liu Huayan, Identification of Temporal Characteristic Networks of Peripheral Blood Changes in Alzheimer’s Disease Based on Weighted Gene Co-expression Network Analysis, Frontiers in Aging Neuroscience, 11, 2019. Crossref

  5. Fraguas-Sánchez Ana I., Torres-Suárez Ana I., Cohen Marie, Delie Florence, Bastida-Ruiz Daniel, Yart Lucile, Martin-Sabroso Cristina, Fernández-Carballido Ana, PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment, Pharmaceutics, 12, 5, 2020. Crossref

  6. Martínez Vicente, Iriondo De-Hond Amaia, Borrelli Francesca, Capasso Raffaele, del Castillo María Dolores, Abalo Raquel, Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?, International Journal of Molecular Sciences, 21, 9, 2020. Crossref

  7. Wright Madison, Di Ciano Patricia, Brands Bruna, Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence, Cannabis and Cannabinoid Research, 5, 3, 2020. Crossref

  8. Neumann Alexander, Engel Viktor, Mahardhika Andhika B., Schoeder Clara T., Namasivayam Vigneshwaran, Kieć-Kononowicz Katarzyna, Müller Christa E., Computational Investigations on the Binding Mode of Ligands for the Cannabinoid-Activated G Protein-Coupled Receptor GPR18, Biomolecules, 10, 5, 2020. Crossref

  9. McCartney Danielle, Benson Melissa J., Desbrow Ben, Irwin Christopher, Suraev Anastasia, McGregor Iain S., Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research, Sports Medicine - Open, 6, 1, 2020. Crossref

  10. Momekova Denitsa, Danov Yavor, Momekov Georgi, Ivanov Ervin, Petrov Petar, Polysaccharide Cryogels Containing β-Cyclodextrin for the Delivery of Cannabidiol, Pharmaceutics, 13, 11, 2021. Crossref

  11. Andriotis Eleftherios G., Chachlioutaki Konstantina, Monou Paraskevi Kyriaki, Bouropoulos Nikolaos, Tzetzis Dimitrios, Barmpalexis Panagiotis, Chang Ming-Wei, Ahmad Zeeshan, Fatouros Dimitrios G., Development of Water-Soluble Electrospun Fibers for the Oral Delivery of Cannabinoids, AAPS PharmSciTech, 22, 1, 2021. Crossref

  12. Alexandra Sulcova, Translational research of antidepressants with an example of cannabidiol effect, Archives of Depression and Anxiety, 2020. Crossref

  13. Wei DanDan, Wang HuiChao, Yang JingNan, Dai ZhiFeng, Yang RuiLin, Meng ShuangShuang, Li YongYu, Lin XuHong, Effects of O‐1602 and CBD on TNBS‐induced colonic disturbances, Neurogastroenterology & Motility, 32, 3, 2020. Crossref

  14. Sahinovic Ayshe, Irwin Christopher, Doohan Peter T., Kevin Richard C., Cox Amanda J., Lau Namson S., Desbrow Ben, Johnson Nathan A., Sabag Angelo, Hislop Matthew, Haber Paul S., McGregor Iain S., McCartney Danielle, Effects of Cannabidiol on Exercise Physiology and Bioenergetics: A Randomised Controlled Pilot Trial, Sports Medicine - Open, 8, 1, 2022. Crossref

  15. Li Hang, Zhao Qingsheng, Wang Liwei, Wang Peidong, Zhao Bing, Cannabidiol/hydroxypropyl-β-cyclodextrin inclusion complex: structure analysis, release behavior, permeability, and bioactivity under in vitro digestion, New Journal of Chemistry, 46, 10, 2022. Crossref

  16. Diaz Monica M., Caylor Jacob, Strigo Irina, Lerman Imanuel, Henry Brook, Lopez Eduardo, Wallace Mark S., Ellis Ronald J., Simmons Alan N., Keltner John R., Toward Composite Pain Biomarkers of Neuropathic Pain—Focus on Peripheral Neuropathic Pain, Frontiers in Pain Research, 3, 2022. Crossref

  17. Salehi Arash, Puchalski Keely, Shokoohinia Yalda, Zolfaghari Behzad, Asgary Sedigheh, Differentiating Cannabis Products: Drugs, Food, and Supplements, Frontiers in Pharmacology, 13, 2022. Crossref

  18. Tabnak Peyman, Masrouri Soroush, Mafakheri Asrin, Natural products in suppressing glioma progression: A focus on the role of microRNAs , Phytotherapy Research, 36, 4, 2022. Crossref

  19. Kumar Pradeep, Mahato Dipendra Kumar, Kamle Madhu, Borah Rituraj, Sharma Bharti, Pandhi Shikha, Tripathi Vijay, Yadav Hardeo Singh, Devi Sheetal, Patil Umesh, Xiao Jianbo, Mishra Awdhesh Kumar, Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: An overview , Phytotherapy Research, 35, 11, 2021. Crossref

  20. Zorzenon Maria Rosa Trentin, Santiago Amanda Nunes, Mori Marco Aurélio, Piovan Silvano, Jansen Cler Antônia, Perina Padilha Maria Eduarda, Ciotta Simone Rocha, Cezar de Freitas Mathias Paulo, Guimarães Francisco Silveira, Weffort de Oliveira Rubia Maria, Milani Paula Gimenez, Mareze-Costa Cecília Edna, Cannabidiol improves metabolic dysfunction in middle-aged diabetic rats submitted to a chronic cerebral hypoperfusion, Chemico-Biological Interactions, 312, 2019. Crossref

  21. Berk Klaudia, Konstantynowicz-Nowicka Karolina, Charytoniuk Tomasz, Harasim-Symbor Ewa, Chabowski Adrian, Distinct Effects of Cannabidiol on Sphingolipid Metabolism in Subcutaneous and Visceral Adipose Tissues Derived from High-Fat-Diet-Fed Male Wistar Rats, International Journal of Molecular Sciences, 23, 10, 2022. Crossref

近刊の記事

PRMT6 promotes the immune evasion of gastric cancer via upregulating ANXA1 Liang Xu, Fenger Zhang, Binqi Yu, Shengnan Jia, Sunfu Fan PURPL promotes M2 macrophage polarization in lung cancer via regulating RBM4/xCT signaling Jipeng Guo, Chongwen Gong, Hao Wang SIAH1 promotes the pyroptosis of cardiomyocytes in diabetic cardiomyopathy via regulating IκB-α/NF-κB signaling Jinbin Wu, Yaoming Yan SLC7A2-mediated lysine catabolism inhibits immunosuppression in triple negative breast cancer Yuanyuan Sun, Yaqing Li, Chengying Jiang, Chenying Liu, Yuanming Song SIAH2-mediated degradation of ACSL4 inhibits the anti-tumor activity of CD8+ T cells in hepatocellular carcinoma Fangzheng Shu, Yuhua Shi, Xiangxiang Shan, Wenzhang Zha, Rengen Fan, Wanjiang Xue RBM15-mediated N6-methyl adenosine (m6A) modification of EZH2 drives the epithelial-mesenchymal transition of cervical cancer Ruixue Wang, Wenhua Tan Evidence-Based Storytelling and A Strategic Roadmap to Promote Cancer Prevention Via Adolescent HPV Vaccination in Northern New England Matthew Dugan, Gary Stein, Jan Carney, Sheila Clifford-Bova KDM4A-AS1 promotes cell proliferation, migration and invasion via the miR-4306/STX6 axis in hepatocellular carcinoma Wei Cao, Yuhan Ren, Ying Liu, Guoshu Cao, Zhen Chen, Fan Wang HDAC1-mediated downregulation of NEU1 exacerbates the aggressiveness of cervical cancer Nanzi Xie, Sisi Mei, Changlan Dai, Wei Chen Effect of miR-26b-5p on progression of acute myeloid leukemia by regulating USP48-mediated Wnt/β-catenin pathway Yu Xie, Lin Tan, Kun Wu, Deyun Li, Chengping Li
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集 価格及び購読のポリシー Begell House 連絡先 Language English 中文 Русский Português German French Spain